The IBD Project
Illuminating change.
Amid a complex competitive landscape, Takeda saw an opportunity to support healthcare professionals and their patients with inflammatory bowel disease (IBD) with a fresh take on education and advocacy. Pivot was brought in to name, brand, and build the overarching platform from the ground up.
Our strategy highlighted the grassroots energy and passion behind the push—a bold, collaborative response to the needs of the IBD community. Introducing The IBD Project: a vision for elevated patient care, brought to light.
We are SO appreciative of the countless hours, late nights, and weekends that enabled us to reach this milestone launch moment. We have created something truly spectacular. It’s incredible.
Stephanie Lynch
Associate Director, IBD Strategy
©2025 Takeda Pharmaceuticals U.S.A., Inc. All rights reserved. Takeda and the Takeda Logo are registered trademarks of Takeda Pharmaceutical Company Limited. IBDIQ is a trademark of Takeda Pharmaceuticals U.S.A., Inc.